These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 26298350)

  • 21. Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study.
    Lee DS; Evans JC; Robins SJ; Wilson PW; Albano I; Fox CS; Wang TJ; Benjamin EJ; D'Agostino RB; Vasan RS
    Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):127-33. PubMed ID: 17095717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated circulating lipocalin-2 levels independently predict incident cardiovascular events in men in a population-based cohort.
    Wu G; Li H; Fang Q; Jiang S; Zhang L; Zhang J; Hou X; Lu J; Bao Y; Xu A; Jia W
    Arterioscler Thromb Vasc Biol; 2014 Nov; 34(11):2457-64. PubMed ID: 25189569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of non-traditional biomarkers, and combinations of biomarkers, for vascular risk prediction in people with type 2 diabetes: The Edinburgh Type 2 Diabetes Study.
    Price AH; Weir CJ; Welsh P; McLachlan S; Strachan MWJ; Sattar N; Price JF
    Atherosclerosis; 2017 Sep; 264():67-73. PubMed ID: 28777936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single and multiple cardiovascular biomarkers in subjects without a previous cardiovascular event.
    Pareek M; Bhatt DL; Vaduganathan M; Biering-Sørensen T; Qamar A; Diederichsen AC; Møller JE; Hindersson P; Leósdóttir M; Magnusson M; Nilsson PM; Olsen MH
    Eur J Prev Cardiol; 2017 Oct; 24(15):1648-1659. PubMed ID: 28644092
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apolipoprotein CIII and N-terminal prohormone b-type natriuretic peptide as independent predictors for cardiovascular disease in type 2 diabetes.
    Colombo M; Looker HC; Farran B; Agakov F; Brosnan MJ; Welsh P; Sattar N; Livingstone S; Durrington PN; Betteridge DJ; McKeigue PM; Colhoun HM
    Atherosclerosis; 2018 Jul; 274():182-190. PubMed ID: 29793175
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma Levels of Fatty Acid-Binding Protein 4, Retinol-Binding Protein 4, High-Molecular-Weight Adiponectin, and Cardiovascular Mortality Among Men With Type 2 Diabetes: A 22-Year Prospective Study.
    Liu G; Ding M; Chiuve SE; Rimm EB; Franks PW; Meigs JB; Hu FB; Sun Q
    Arterioscler Thromb Vasc Biol; 2016 Nov; 36(11):2259-2267. PubMed ID: 27609367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mild hyponatremia, hypernatremia and incident cardiovascular disease and mortality in older men: A population-based cohort study.
    Wannamethee SG; Shaper AG; Lennon L; Papacosta O; Whincup P
    Nutr Metab Cardiovasc Dis; 2016 Jan; 26(1):12-9. PubMed ID: 26298426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Copeptin and the risk of incident stroke, CHD and cardiovascular mortality in older men with and without diabetes: The British Regional Heart Study.
    Wannamethee SG; Welsh P; Lennon L; Papacosta O; Whincup PH; Sattar N
    Diabetologia; 2016 Sep; 59(9):1904-12. PubMed ID: 27312697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-Sensitivity Cardiac Troponin I for Risk Stratification in Older Adults.
    Tang O; Matsushita K; Coresh J; Hoogeveen RC; Windham BG; Ballantyne CM; Selvin E
    J Am Geriatr Soc; 2021 Apr; 69(4):986-994. PubMed ID: 33150614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hierarchical modelling of blood lipids' profile and 10-year (2002-2012) all cause mortality and incidence of cardiovascular disease: the ATTICA study.
    Nomikos T; Panagiotakos D; Georgousopoulou E; Metaxa V; Chrysohoou C; Skoumas I; Antonopoulou S; Tousoulis D; Stefanadis C; Pitsavos C;
    Lipids Health Dis; 2015 Sep; 14():108. PubMed ID: 26370413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Higher Serum Sex Hormone-Binding Globulin Levels Are Associated With Incident Cardiovascular Disease in Men.
    Gyawali P; Martin SA; Heilbronn LK; Vincent AD; Jenkins AJ; Januszewski AS; Adams RJT; O'Loughlin PD; Wittert GA
    J Clin Endocrinol Metab; 2019 Dec; 104(12):6301-6315. PubMed ID: 31390027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of Plasma γ' Fibrinogen With Incident Cardiovascular Disease: The Atherosclerosis Risk in Communities (ARIC) Study.
    Appiah D; Schreiner PJ; MacLehose RF; Folsom AR
    Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2700-6. PubMed ID: 26494231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac and kidney markers for cardiovascular prediction in individuals with chronic kidney disease: the Atherosclerosis Risk in Communities study.
    Matsushita K; Sang Y; Ballew SH; Astor BC; Hoogeveen RC; Solomon SD; Ballantyne CM; Woodward M; Coresh J
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1770-7. PubMed ID: 24876355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multimodality Strategy for Cardiovascular Risk Assessment: Performance in 2 Population-Based Cohorts.
    de Lemos JA; Ayers CR; Levine BD; deFilippi CR; Wang TJ; Hundley WG; Berry JD; Seliger SL; McGuire DK; Ouyang P; Drazner MH; Budoff M; Greenland P; Ballantyne CM; Khera A
    Circulation; 2017 May; 135(22):2119-2132. PubMed ID: 28360032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma calprotectin and risk of cardiovascular disease: Findings from the PREVEND prospective cohort study.
    Kunutsor SK; Flores-Guerrero JL; Kieneker LM; Nilsen T; Hidden C; Sundrehagen E; Seidu S; Dullaart RPF; Bakker SJL
    Atherosclerosis; 2018 Aug; 275():205-213. PubMed ID: 29957458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence of cardiovascular disease and its associated risk factors in at-risk men and women in the United Arab Emirates: a 9-year retrospective cohort study.
    Al-Shamsi S; Regmi D; Govender RD
    BMC Cardiovasc Disord; 2019 Jun; 19(1):148. PubMed ID: 31208354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Longitudinal increases in blood biomarkers of inflammation or cardiovascular disease and the incidence of venous thromboembolism.
    Folsom AR; Lutsey PL; Heckbert SR; Poudel K; Basu S; Hoogeveen RC; Cushman M; Ballantyne CM
    J Thromb Haemost; 2018 Oct; 16(10):1964-1972. PubMed ID: 30007116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. C-reactive protein, interleukin-6 and tumor necrosis factor alpha as predictors of incident coronary and cardiovascular events and total mortality. A population-based, prospective study.
    Tuomisto K; Jousilahti P; Sundvall J; Pajunen P; Salomaa V
    Thromb Haemost; 2006 Mar; 95(3):511-8. PubMed ID: 16525580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Associations of time of day with cardiovascular disease risk factors measured in older men: results from the British Regional Heart Study.
    Sartini C; Whincup PH; Wannamethee SG; Jefferis BJ; Lennon L; Lowe GD; Welsh P; Sattar N; Morris RW
    BMJ Open; 2017 Nov; 7(11):e018264. PubMed ID: 29133328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Associations of pentraxin 3 with cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis.
    Jenny NS; Blumenthal RS; Kronmal RA; Rotter JI; Siscovick DS; Psaty BM
    J Thromb Haemost; 2014 Jun; 12(6):999-1005. PubMed ID: 24628740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.